Page 139 - Orange Book Cumulative Supplement 10 October 2012

A - 2
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content

PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN - EXFORGE HCT
N022314 002 8101599 May 16, 2023 DP
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN - EXFORGE HCT
N022314 003 8101599 May 16, 2023 DP
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN - EXFORGE HCT
N022314 004 8101599 May 16, 2023 DP
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN - EXFORGE HCT
N022314 005 8101599 May 16, 2023 DP

APREPITANT - EMEND
N021549 001 8258132 Sep 26, 2027 DP U-901
8258132 Sep 26, 2027 DP U-1282
APREPITANT - EMEND
N021549 002 8258132 Sep 26, 2027 DP U-901
8258132 Sep 26, 2027 DP U-1282
APREPITANT - EMEND
N021549 003 8258132 Sep 26, 2027 DP U-901
8258132 Sep 26, 2027 DP U-1282

ARFORMOTEROL TARTRATE - BROVANA
N021912 001 6589508 Apr 03, 2013 U-793
6667344 Jun 22, 2021 DP
6814953 Jun 22, 2021 U-793
8110706 Nov 09, 2021 DP
ARSENIC TRIOXIDE - TRISENOX
N021248 001 >A> 8273379 Nov 10, 2018 U-1291

ATOVAQUONE; PROGUANIL HYDROCHLORIDE - ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
A091211 001 PC Mar 13, 2012
AVANAFIL - STENDRA
N202276 001 6656935 Sep 13, 2020 DS DP U-155 NCE Apr 27, 2017
>A> 7501409 May 05, 2023 DP
AVANAFIL - STENDRA
N202276 002 6656935 Sep 13, 2020 DS DP U-155 NCE Apr 27, 2017
>A> 7501409 May 05, 2023 DP

AVANAFIL - STENDRA
N202276 003 6656935 Sep 13, 2020 DS DP U-155 NCE Apr 27, 2017
>A> 7501409 May 05, 2023 DP
AXITINIB - INLYTA
N202324 001 6534524 Jun 30, 2020 DS DP NCE Jan 27, 2017
7141581 Jun 30, 2020 U-1220
AXITINIB - INLYTA
N202324 002 6534524 Jun 30, 2020 DS DP NCE Jan 27, 2017
7141581 Jun 30, 2020 U-1220